Performance of immunochemical faecal occult blood test in colorectal cancer screening in average‐risk population according to positivity threshold and number of samples
Open Access
- 3 March 2009
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 125 (5), 1127-1133
- https://doi.org/10.1002/ijc.24407
Abstract
Immunochemical faecal occult blood tests (I-FOBT) detect more effectively advanced neoplasia than guaiac tests (G-FOBT). The study aim was to compare the performance of an I-FOBT whilst varying the positivity threshold and considering four analysis modalities: one sample was performed (MG1), two samples were performed and at least one sample was positive (MG2+), both samples were positive (MG2++) or the mean of the two samples' log-transformed haemoglobin contents exceeded the cutoff (MG2m). Screening for colorectal cancer using both G-FOBT and two samples' I-FOBT was performed by an average-risk population sample of 20,322 subjects. Among the 1,615 subjects with at least one positive test, 1,277 had a satisfactory colonoscopy result; 43 invasive cancers and 270 high-risk adenomas were detected. The I-FOBT was reinterpreted under each analysis modality (a random selection of one sample led to MG1). For all modalities, increasing the positivity threshold decreased sensitivity and increased specificity. The relative ROC curves (in reference to G-FOBT) demonstrated similar performance for MG1 and MG2+, and improved performance for MG2m. MG2++ sensitivity was limited within the range of positivity thresholds evaluated. For any specificity, MG2m provided the highest sensitivity. For any sensitivity, MG2m provided the highest specificity. For any positivity rate, MG2m provided both the highest sensitivity and specificity. This study suggests the replacement of MG2+ by MG1 or, for even better performance, by MG2m provided that two samples are performed with similar participation (which should be explored). The targeted positivity rate could then be achieved by choosing the positivity threshold. © 2009 UICCKeywords
This publication has 24 references indexed in Scilit:
- What is the role of iFOBT in screening for colorectal cancer?Gut, 2007
- Screening for Colorectal Neoplasms With New Fecal Occult Blood Tests: Update on Performance CharacteristicsJNCI Journal of the National Cancer Institute, 2007
- Which Colorectal Cancer Screening Test Is Best?JNCI Journal of the National Cancer Institute, 2007
- Sensitivity of latex agglutination faecal occult blood test in the Florence District population-based colorectal cancer screening programmeBritish Journal of Cancer, 2007
- Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk populationGut, 2007
- Association of FOBT-assessed faecal Hb content with colonic lesions detected in the Florence screening programmeBritish Journal of Cancer, 2007
- Colon Cancer Screening Guidelines 2005: The Fecal Occult Blood Test Option Has Become a Better FITGastroenterology, 2005
- Evaluation of an immunochemical fecal occult blood test with automated reading in screening for colorectal cancer in a general average‐risk populationInternational Journal of Cancer, 2005
- Cost‐effectiveness analysis of two strategies for mass screening for colorectal cancer in FranceHealth Economics, 2003